Is Amphastar Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-05 11:20:47As of 31 October 2025, the technical trend for Amphastar Pharmaceuticals, Inc. has changed from sideways to mildly bullish. However, the overall technical indicators present a mixed picture. The MACD is bearish on both weekly and monthly timeframes, while the RSI shows no signal. Moving averages are bearish on a daily basis, and the KST is mildly bearish weekly and bearish monthly. Dow Theory indicates a mildly bullish stance on the weekly timeframe but shows no trend monthly. Despite the recent mild bullish trend, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -31.97% compared to the S&P's 16.30%, and a one-year return of -50.21% versus 19.89% for the index. Overall, the technical stance is mildly bullish but weak, with key indicators suggesting caution....
Read More
Amphastar Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead
2025-11-04 15:26:24Amphastar Pharmaceuticals, Inc. has encountered a technical event known as a Death Cross, indicating bearish sentiment in its stock performance. The company has seen a significant decline over the past year, underperforming against the S&P 500, and its technical indicators suggest ongoing challenges in the market.
Read MoreIs Amphastar Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-04 11:32:14As of 31 October 2025, the technical trend for Amphastar Pharmaceuticals, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD readings are bearish. The KST shows bullish momentum on the weekly but bearish on the monthly. Dow Theory supports a mildly bullish outlook in both weekly and monthly time frames, and the OBV also reflects a mildly bullish trend. In terms of performance, the stock has underperformed significantly against the S&P 500 over the past year, down 50.13% compared to the S&P's 19.89% gain, and has a negative return of 31.86% year-to-date versus the S&P's 16.30%. Overall, the current technical stance is mildly bullish, but the bearish signals in the MACD and Bollinger Bands suggest caution....
Read MoreIs Amphastar Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-03 11:31:39As of 31 October 2025, the technical trend for Amphastar Pharmaceuticals, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and Bollinger Bands show bearish signals. However, the KST and Dow Theory are both mildly bullish on a weekly basis. The overall technical stance is mildly bullish, driven primarily by the daily moving averages and the weekly KST and Dow Theory indicators. In terms of performance, the stock has underperformed significantly compared to the S&P 500 over the past year, with a return of -49.53% versus the S&P 500's 19.89%....
Read MoreIs Amphastar Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-02 11:17:07As of 31 October 2025, the technical trend for Amphastar Pharmaceuticals, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD readings are bearish. The KST shows a bullish signal on the weekly timeframe but bearish on the monthly. Dow Theory supports a mildly bullish outlook on both weekly and monthly bases, and the OBV is also mildly bullish. In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -31.32% compared to the S&P 500's 16.30%, and a one-year return of -49.53% against 19.89% for the benchmark. Overall, the current technical stance is mildly bullish, but the stock's performance relative to the S&P 500 suggests significant underperformance....
Read More
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout
2025-10-15 15:28:41Amphastar Pharmaceuticals has recently experienced a Golden Cross, a technical event that may signal a shift in momentum. Despite a significant decline over the past year, the stock's daily moving averages show mildly bullish tendencies, attracting investor interest amid ongoing caution reflected in other technical indicators.
Read More





